Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Pharming awarded grants for human lactoferrin research; announces collaboration

Oct. 5, 1999

New sulfonamide anticoagulants in the Takeda pipeline

Sep. 28, 1999

Tanabe Seiyaku presents PAI-1 inhibitors as antithrombotics

Sep. 27, 1999

Meiji Seika's new integrin receptor antagonists useful as antiplatelet, antiadhesion agents

Sep. 22, 1999

Health Canada approves Aggrastat for management of unstable angina

Sep. 20, 1999

Mediolanum and Dompe introduce new agent for preventing DVT in Italy

Sep. 20, 1999

Human factor Xa inhibitors under evaluation at Roche Diagnostics

Sep. 16, 1999

Corvas and Schering-Plough extend oral anticoagulant research program

Sep. 15, 1999

International patent covers Roche Diagnostics' new anticoagulants

Sep. 15, 1999

Prophylaxis of venous thromboembolism with enoxaparin assessed in hospitalized patients

Sep. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...